General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0YLNPN
ADC Name
BRY-812
Synonyms
BRY 812; BRY-812; BRY812
   Click to Show/Hide
Organization
BioRay Biopharmaceutical Co., Ltd.
Drug Status
Phase 1
Indication
In total 1 Indication(s)
Solid tumor
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
Undisclosed
Antibody Name
Undisclosed
Antigen Name
Zinc transporter ZIP6 (SLC39A6)
 Antigen Info 
Payload Name
Monomethyl auristatin E
 Payload Info 
Therapeutic Target
Microtubule (MT)
 Target Info 
Linker Name
Undisclosed
Conjugate Type
Undisclosed